Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274


Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.

Paick JS, Choi HK, Kim SC, Ahn TY, Kim JJ, Park JK, Park KS, Lee SW, Kim SW, Park K, Jung H, Park NC.

Asian J Androl. 2008 Sep;10(5):791-8. doi: 10.1111/j.1745-7262.2008.00422.x.


Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.


Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.

Carson C, Shabsigh R, Segal S, Murphy A, Fredlund P, Kuepfer C; Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group.

Urology. 2005 Feb;65(2):353-9.


Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.

Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.

Eur Urol. 2004 Sep;46(3):362-9; discussion 369.


Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.

Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H; Vardenafil Study Group.

Urology. 2003 Apr;61(4 Suppl 1):8-14.


Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.

Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX, Cheong NF, Lim E, Shen W, Venugopalan M, Chan M.

Int J Urol. 2006 Jun;13(6):721-7.


Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.

Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T; Vardenafil Diabetes Study Group.

Diabetes Care. 2003 Mar;26(3):777-83.


A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea.

Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS, Suh JK, Kim HS, Kim YK, Lee WH, Oh BH, Park CH, Ryu WS, Chung TG, Kim SW, Lee WH, Moon DG, Ryu DS, Seo KK, Kim DK, Lee DS.

Int J Impot Res. 2003 Apr;15(2):80-6.


The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study.

Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, Tantiwong A; Thai investigators in ASSESS-2 Study Group.

J Med Assoc Thai. 2003 Mar;86(3):195-205.


Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.

Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.

Arch Neurol. 2007 Nov;64(11):1584-92. Epub 2007 Sep 10.


Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.

Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, Schnetzler G.

BJU Int. 2008 Dec;102(11):1645-50. doi: 10.1111/j.1464-410X.2008.07908.x. Epub 2008 Aug 14.


Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.

Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, Ishii N, Kamidono S.

Urology. 2006 Oct;68(4):845-51.


Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.

Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S.

Int J Urol. 2006 Aug;13(8):1066-72.


Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan.

Nagao K, Ishii N, Kamidono S, Osada T; Vardenafil (Levitra) Clinical Trial Group.

Int J Urol. 2004 Jul;11(7):515-24.


The efficacy and safety of tadalafil: an update.

Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ, Shen W, Cordell WH.

BJU Int. 2004 Jun;93(9):1276-81.


Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.

Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V.

Asian J Androl. 2006 Nov;8(6):685-92. Epub 2006 Jul 11. Erratum in: Asian J Androl. 2007 Jan;9(1):39.


Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.

Eur Urol. 2006 Aug;50(2):351-9. Epub 2006 Mar 20.


Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ.

J Clin Psychiatry. 2006 Feb;67(2):240-6.


Supplemental Content

Support Center